Clinical profile of Ioversol a metaanalysis of 57 randomized, double- blind clinical trials

Investigative Radiology

Volumn 31, Issue 8, 1996, Pages 479-491

  Floriani, Irene ^a,d   Ciceri, M ^a   Torri, V ^b   Tinazzi, A ^b   Jahn, H ^c   Noseda, A ^a  

^a Byk Gulden Italia   (Italy)

^b Ist Ricerdie Farmacologiche M Neg   (Italy)

^c Mallinckrodt Medical GmbH   (Germany)

^d Byk Gulden Italia SpA   (Italy)

Author keywords

Ioversol; metaanalysis; nonionic contrast media

Indexed keywords

IOVERSOL; NONIONIC CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; GASTROINTESTINAL TOXICITY; HEAT SENSATION; HUMAN; IMAGE QUALITY; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; META ANALYSIS; NEUROTOXICITY; NOCICEPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SKIN TOXICITY;

EID: 0029781556     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199608000-00003     Document Type: Article

References (46)

1. McClennan BL. Low-osmolality contrast media: Premises and promises. Radiology 1987;162:1-8.
2. Le Mignon MM, Azau C, Arthaud A, Bonnemain B. Preliminary european intravenous clinical experience with a new, low osmolar, nonionic contrast medium: Ioversol (Optiray®). Eur J Radiol 1991;13:126-133.
3. Bonnemain B, Meyer D, Schaefer M, Dugast-Zrihen M, Legreneur S, Doucet D. New iodinated, low-osmolar contrast media: A revised concept of hydrophilicity. Invest Radiol 1990;S104-S106.
4. Meyer D, Bonnemain B, Dugast-Zrihen M, Legreneur S. Hydrophilie faciale équilibrée du ioversol: Une approche qualitative de l'hydrophilie. Ann Radiol 1992;35:263-266.
5. Doucet D, Idee JM. Profil pharmacotoxicologique d'un LOCM non ionique à haute hydrophilie: Ioversol. Ann Radiol 1992;35: 267-272.
6. Morimoto S, Kozuka T, Takamya M, et al. Usefulness of ioversol (MP-328) in angiocardiography: A multicenter comparative study with Iopamidol. Nippon Acta Radiologica 1990;50:1087-1101.
7. Stacul F, Bazzocchi M, Bortolotto P, Gandin F, Spinazzi A, Cattaneo G. Ioversolo versus Iohexolo in urografia: Studio in doppio cieco randomizzato. Italian Current Radiology 1991;X(n.1/2): 65-68.
8. Orsi F, Bezzi M, Ricci P, Rossi M, Salvatori FM, Rossi P. Studio comparativo tra Ioversolo, Iopamidolo e Iohexolo nell'arteriografia periferica e viscerale. In: Simonetti G, Pavone P, De Pascale A, Miotto D, Stacul F eds. Contributo della ricerca italiana nello sviluppo dei mezzi di contrasto. SIRM 1992:63-72.
9. Lawrence V, Matthai W, Hartmaier S. Comparative safety of high-osmolality and low-osmolality radiographic contrast agents. Report of a multidisciplinary working group. Invest Radiol 1992;27:2-27.
10. Jusuf S, Peto R, Lewis J, Collins R, Sleight T. Beta blockade during and after myocardial infarction: An overview of randomised clinical trials. Prog Cardiovasc Dis 1985:27:335-371.
11. Early Breast Cancer Trialists' Collaborative Group. Treatment of early breast cancer. Vol 1. Worldwide evidence 1985-1990. Oxford: Oxford University Press, 1990.
12. Reagan K, Bettman MA, Finkelstein J, Ganz P, Grassi CJ. Double-blind study of a new nonionic contrast agent for cardiac angiography. Radiology 1988;167:409-413.
13. Grassi CJ, Bettman MA, Finkelstein J, Reagan K. Ioversol: Double-blind study of a new low osmolar contrast agent for peripheral and visceral arteriography. Invest Radiol 1989;24:133-137.
14. Scott H, Palmer FJ. Ioversol in ascending phlebography: A clinical trial. Australas Radiol 1990;1:44-46.
15. Cappellini M, Villa G. Efficacia diagnostica e tollerabilità di un nuovo mezzo di contrasto non ionico a bassa osmolarità (Optiray) nello studio della patologia encefalica vascolare e neoplastica. In: Simonetti G, Pavone P, De Pascale A, Miotto D, Stacul F eds. Contributo della ricerca italiana nello sviluppo dei mezzi di contrasto. SIRM 1992:55-62.
16. Heiken JP, Brink JA, McClennan BL, Sagel SS, Crowe TM, Gaines MV. Dynamic contrast-enhanced CT of the liver: Comparison of volumes and concentrations of contrast media. Radiology 1993;189(suppl):176.
17. Miller FJ, Polley S, Osborne AG. Efficacy, safety, and tolerability of ioversol in intraarterial digital subtraction angiography. Invest Radiol 1989:24(suppl 1):S52-S54.
18. Gado MH, Sartor K, Hodges FJ. Clinical experience with ioversol 320 in cranial computed tomographic scanning. Invest Radiol 1989;24(suppl 1):S29-S32.
19. Kopecky KK, Becker GJ, Conces DJ Jr. Ioversol 320: A new nonionic, water-soluble contrast medium for body computed tomography: Clinical trial. Invest Radiol 1989;24(suppl 1):S33-S34.
20. Ogawa K, Ido K, Endo M, et al. Clinical evaluation of ioversol in selective visceral angiography. Rinsho Iyaku 1990;6:31-42.
21. Hiramatsu K, Ogawa K, Uchida H, et al. Ioversol in visceral angiography: Multicenter trial. Journal of Japanese College of Angiology 1990;30:1101-1108.
22. Theron J, Paugam JP, Chourtheoux P. Ioversol 350: Expérience clinique en tomodensitométrie cranienne. Ann Radiol 1991;34: 413-417.
23. Lemaitre L. Evaluation de l'efficacité et de la tolérance du ioversol en urographie intraveineuse. Ann Radiol 1992;35:303-306.
24. Lupoi D, Carpanese L, Squillaci G, Ferreri G, Giunta S, Simonetti G. Sicurezza ed efficacia dello Ioversolo 320 nello studio del fegato mediante TC spirale. In: Simonetti G, Pavone P, De Pascale A, Miotto D, Stacul F eds. Contributo della ricerca italiana nello sviluppo dei mezzi di contrasto. SIRM 1994:11-15.
25. Eilenberg SS, Lee JK, Brown JJ, Mirowitz SA, Tartar VM. Renal masses: Evaluation with gradient-echo Gd-DTPA - enhanced dynamic MR imaging. Radiology 1990;176:333-338.
26. Kuhn MJ, Long SD, DeSio MA. Low-osmolality contrast media: Dosage comparison of ioversol and iohexol for cranial computed tomography. Comput Med Imaging Graph 1991;15:403-406.
27. Baker ME, Durham NC, Beam CA, Leder RA, Gulliver DJ, Dunnick NR. Volume of nonionic contrast media for dynamic abdominal/pelvic CT: 125 mL Ioversol-320 versus 150 mL Iopamidol-300. Radiology 1991;181(P):286. Abstract.
28. Kern MJ, Roth RA, Aguirre FV, Beauman G, Vogel R. Effect of viscosity and iodine concentration of nonionic radiographic contrast media on coronary arteriography in patients. Am Heart J 1992;123:160-165.
29. Kaufman AJ, Concepcion R, Kirchner FK Jr, McDougal WS, Winfield AC. Ioversol for intravenous urography: A comparison study. Urol Radiol 1990;12:56-60.
30. Colthurst JR, Chan O, Creagh M, et al. A double-blind clinical study comparing the safety, tolerance and efficacy of ioversol and iohexol in intravenous urography. Clin Radiol 1990;42: 174-176.
31. McGaughey MD, Remetz MS, Scharf-Bornhofen E. A double-blind study comparing the safety, tolerability and efficacy of ioversol 350 and Iohexol 350 in coronary arteriography with left ventriculography. J Invas Cardiol 1991;3:272-77.
32. Halpin SF, Featherstone T, Byrne JV, Britton JA. Ioversol in leg venography. Clin Radiol 1990;42:448. Letter.
33. Cutcliff WB, Schwarten DE. A double-blind comparative study of the safety, tolerability, and efficacy of ioversol and iohexol in peripheral and visceral arteriography. Invest Radiol 1989; 24(suppl 1):S56-S59.
34. Ringel K, Kuehn J. A double-blind study comparing the safety, tolerability, and efficacy of ioversol 320 and iopamidol 300 in cerebral angiography. Invest Radiol 1989;24(suppl 1):S48-S51.
35. Rieser R, Beinborn W, Ney N. A double-blind comparative study on the contrast quality, tolerance, and safety of ioversol 300 versus iohexol 300 in central venous angiography (CV DSA). Ann Radiol 1992;35(4bis):311-314.
36. Wilkins RA, Spinks BC. A double-blind clinical study comparing the safety, tolerance, and efficacy of ioversol 240 and iohexol 240 in ascending venography. Clin Radiol 1990;41:268-271.
37. Joffre F, Rousseau H, Aziza R. Evaluation de l'efficacité et de la tolérance du ioversol en urographie intraveineuse. Ann Radiol 1992;35:288-292.
38. Voegeli E, Woessmer B. Evaluation de la tolérance clinique et de l'efficacité diagnostique du Ioversol 350 en UIV. Ann Radiol 1992;35:293-296.
39. Chagnaud Ch, Moulin G, Delannoy L, et al. Ioversol 300 et Iopamidol 300 en tomodensitométrie "corps-entier". Essai clinique en double insu. Ann Radiol 1992;35(4bis):276-279.
40. Hoogewoud HM, Neiss AC, Woessmer B. Etude randomisée en double aveugle comparant Ioversol 300 et Iopromide 300 en tomodensitométrie abdominale (CT-scanner). Ann Radiol 1992;35 (4bis):273-275.
41. Kuhn MJ, Baker MR. Optimization of low-osmolality contrast media for cranial CT: A dose comparison of two contrast agents. AJNR Am J Neuroradiol 1990;11:847-849.
42. Sage MR, Evill CA, Fon GT. A randomized double-blind trial of ioversol and iopamidol in contrast-enhanced computed body tomography. Invest Radiol 1989;24(suppl 1):S39-S41.
43. Almen T. Development of nonionic contrast media. Invest Radiol 1985:20:S2-S9.
44. Dawson P. Chemotoxicity of contrast media and clinical adverse effects: A review. Invest Radiol 1985;20:S84-S91.
45. Bonnemain B, Meyer D, Schaefer M, Dugast-Zrihen M, Legreneur S, Doucet D. New iodinated, low-osmolar contrast media: A revised concept of hydrophilicity. Invest Radiol 1990;25:S104-S106.
46. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. Radiology 1990;175:621-628.